Study CONSORT diagram. by Benjamin R. Lewis (22279166)

“…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …”

Baseline characteristics of the study sample^βμ. by Osama Mohamed Ibrahim (12006954)

“…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”

The flow diagram of the study (CONSORT, 2010). by Osama Mohamed Ibrahim (12006954)

“…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”

The concentration of inflammatory parameters (TNF-α and IL-10) in serum (a and b) and burned skin samples (c) of different experimental groups on day 2 and 10. by Omid Mehrpour (9385929)

Serum concentrations of malondialdehyde (a) and super oxide dismutase (b) and NOx (nitrate +nitrite) (c) in different experimental groups on day 2 and 10. by Omid Mehrpour (9385929)

The concentrations of malondialdehyde (a), super oxide dismutase (b), and NOx (nitrate +nitrite)(c) in the burned skin samples of different experimental groups on day 2 and 10. by Omid Mehrpour (9385929)

Renal (urea and creatinine) (a, b) and Liver function (ALT and AST) (c, d) test in serums of different experimental groups and body weight changes (e) on day 10. by Omid Mehrpour (9385929)

Data Sheet 1_Defective proviruses significantly impact viral transcription and immune activation in men and women with HIV-1 subtype C in rural South Africa.pdf by Ninée V. E. J. Buchholtz (20326332)

“…During successful ART, a significant decrease of both the intact and defective proviral reservoir was observed (p<0.0001). …”

Phenotypic characterization of 81-week-old NMIIC KO mice. by Hiroki Hamaguchi (22783780)

Spontaneous physical activity and respiratory quotient (RQ) in WT and NMIIC KO mice. by Hiroki Hamaguchi (22783780)

Comparison of W_max (A), the changes in V_E (B), and W_VT (C) among the three oxygen conditions. by Kazufumi Hisamoto (21416905)

Fiber types and muscle force in the soleus of 18-20-week-old WT and NMIIC KO mice. by Hiroki Hamaguchi (22783780)

Evaluation of mitochondrial protein expression and morphology in NMIIC KO mice. by Hiroki Hamaguchi (22783780)

Expression of non-muscle myosin (NM) IIC in skeletal muscle cells. by Hiroki Hamaguchi (22783780)

Measurement of inflammatory cytokines in liver and heart tissues. by Ayça Toprak-Semiz (22582110)

Comparison of SpO₂ (A), HR (B), SBP (C), and DP (D) on VT among the three oxygen conditions. by Kazufumi Hisamoto (21416905)

Comparison of soleus muscle weight and fiber size histogram between young and aged WT and NMIIC KO mice. by Hiroki Hamaguchi (22783780)

NMIIC expression and muscle weight in the soleus of 82-86-week-old mice. by Hiroki Hamaguchi (22783780)

Comparison of the changes in HR (A), SBP (B), DP (C), and SpO2 (D) during maximal exercise test among the three oxygen conditions. by Kazufumi Hisamoto (21416905)

Intraperitoneal injection protocol for inhibitors (A), inhibitors DAS and Y27632 reduced intestinal permeability (B) and intestinal adult worm burden (C) of infected mice. by Wen Wen Zheng (17721404)